Cite
HARVARD Citation
Quartuccio, L. et al. (n.d.). THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial. Annals of the rheumatic diseases. pp. 294-295. [Online].